(Q38046611)

27 August 2017

title

Of heart and kidney: a complicated love story (English)

1 reference

27 August 2017

2

0 references

Dan Gaiță

series ordinal

1

0 references

Adalbert Schiller

series ordinal

3

0 references

publication date

25 September 2012

1 reference

European Journal of Preventive Cardiology

27 August 2017

published in

1 reference

27 August 2017

volume

21

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

840-846

1 reference

Cardiorenal syndrome: new perspectives

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

The complexity of the cardio-renal link: taxonomy, syndromes, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Prevalence of chronic kidney disease in population-based studies: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

The impact of acute kidney injury on short-term survival in an Eastern European population with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Kidney and brain--a renal perspective of 'Les Liaisons Dangereuses'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

The kidney, a cardiovascular risk marker, and a new target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Chronic kidney disease is associated with angiographic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Cardiac troponins in renal insufficiency: review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Sudden death due to cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Blood pressure control in chronic kidney disease: is less really more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Hypertension in 2010: Blood pressure and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Renal function and outcomes in acute coronary syndrome: impact of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

Epidemiology of CKD in Europe: an uncertain scenario

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312462826

21 January 2018

Identifiers

DOI

10.1177/2047487312462826

1 reference

27 August 2017

1 reference